2012 Annual Report The Federation of American Societies for Experimental Biology (FASEB) advances health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

Representing over 100,000 researchers.

faseb Member Societies

APS The American Physiological Society ASCI The American Society for Clinical Investigation ASBMB American Society for Biochemistry and Molecular Biology SSR Society for the Study of Reproduction ASPET American Society for Pharmacology and TS The Teratology Society Experimental Therapeutics TES The Endocrine Society ASIP American Society for Investigative Pathology ASHG The American Society of Human Genetics ASN American Society for Nutrition EMGS Environmental Mutagenesis and Genomics Society AAI The American Association of Immunologists ISCB International Society for Computational Biology AAA American Association of Anatomists ACSM American College of Sports Medicine PS The Protein Society BMES Biomedical Engineering Society SDB Society for Developmental Biology GSA Genetics Society of America APEPS American Peptide Society AFMR American Federation for Medical Research ABRF The Association of Biomolecular Resource Facilities HCS The Histochemical Society ASBMR The American Society for Bone and SPR Society for Pediatric Research Mineral Research SFG Society for Glycobiology

ii www.faseb.org The Federation of American Societies for Experimental Biology Table of Contents

President’s Report 2 Executive Director’s Report 4 Public Affairs 5 MARC: Maximizing Access to Research Careers 9 The Faseb Journal 10 Science Research Conferences 12 Society Management Services 14 Centennial Events 16 Beaumont Campus 18 FASEB Awards 19 Financial Report 20 FASEB Committees 25 Faseb Member Societies 28 FASEB Departments 33

Representing over 100,000 researchers. Thank you to our volunteers.

FASEB Board

Officers Directors President Parker B. Antin AAA Maurice Manning APEPS Judith S. Bond Thomas O. Baldwin ASBMB Edward R.B. McCabe ASHG President-Elect Judith A. Blake ISCB Elizabeth McNally ASCI Margaret K. Offermann Hannah V. Carey APS Carole Mendelson TES Past President Shu Chien BMES Francis J. Miller AFMR Joseph C. LaManna Sylvia Christakos ASBMR Patricia Morris SSR Vice President for Science Policy Paul Coates ASN James M. Musser ASIP Joseph R. Haywood Brian Cox ASPET Laura Niedernhofer EMGS Treasurer Nancy Denslow ABRF Arthur G. Palmer PS Lynn Wecker Jay C. Dunlap GSA Chester Ray ACSM Secretary Hudson H. Freeze SFG Edward Rosa-Molinar HCS Guy Fogleman Ellen Kraig AAI John R. Schreiber SPR Carole LaBonne SDB Belén Tornesi TS

Other Leadership Positions Advisors Immediate Past Vice President for Robert J. Freishtat AFMR Science Policy Karen R. Jonscher ABRF Margaret K. Offermann Bettie Sue Masters ASBMB Vice President-Elect for Science Policy Peter A. Rubenstein David M. Rocke ISCB All information reported as of December 31, 2012

FASEB Annual Report 2012 1 President’s Report

Judith S. Bond, PhD

It has been a great honor to be President of FASEB during 2012, our centennial year. There were a number of activities, these very successful exchanges, we arranged a reception on and (with generous gifts from FASEB societies and friends) Capitol Hill in which FASEB, on its 100th anniversary, saluted we were able to capitalize on this occasion to bring national the National Institutes of General Medical Sciences on its attention to this very special organization and the work being 50th anniversary. I co-hosted the event with then-President done by its 26 member societies. Joe LaManna. There were over 200 guests, and speakers We began celebrating the Federation’s remarkable history included Senator Bob Casey (D-PA), Representative Chris by launching our centennial website. Many of our member Van Hollen (D-MD), National Institutes of Health (NIH) Director societies ran special “Stand up for Science” announcements Francis Collins, and Nobel Laureates Tom Cech, Andy Fire, in their publications. FASEB received commemorative state- and Rod MacKinnon. A staff picnic on campus in September ments from state and local governments, and Chemical and and a commemorative meeting in the Cleveland hotel where Engineering News ran a feature story about us. FASEB was founded rounded out the celebrations.

While the year ended without resolution of the funding issues, our voice was among the strongest in support of investment in research.

FASEB President Dr. Joseph LaManna, FASEB President-Elect Dr. Judith Bond, and NIGMS Acting Director Dr. Judith Greenberg with Nobel Laureates Dr. Roderick MacKinnon, Dr. Andrew Fire, and Dr. Thomas Cech at FASEB’s Centennial and NIGMS’ 50th Anniversary Celebration on Capitol Hill

One of my centennial goals was to strengthen the Feder- ation. I met with the councils of ten member societies, while FASEB Past President Joe LaManna and the public affairs staff met with several others. We also hosted a meeting of Society Presidents in conjunction with the May meeting of the FASEB Board.

A highlight of the centennial activities was the Capitol Hill Day and Reception. FASEB Board Members, FASEB Past Presidents, and member society Presidents came to President-Elect Dr. Judith Bond proudly displaying her license plate in Washington to meet with members of Congress. Following recognition of FASEB celebrating its centennial

2 www.faseb.org The Federation of American Societies for Experimental Biology In 2012 we mounted a very active campaign on behalf conference call with Francis Collins for the FASEB Board, of federal research funding. Joe LaManna and I met with Science Policy Committee (SPC), and Member Society Presi- reporters to present our recommendations which were dents to discuss the threat of sequestration. subsequently cited in a “Dear Colleague” letter circulated by Funding was not our only area of engagement in 2012. We Representatives Edward Markey (D-MA) and Brian Bilbray championed the perspective of the biomedical research (R-CA) and signed by 153 members of the House of Repre- community on a wide range of policy issues including sentatives. To bolster our advocacy we submitted testimony workforce and animal research. FASEB’s positions on the to ten Appropriations Subcommittees, and I testified in NIH Biomedical Workforce and Diversity Working Group person on behalf of the National Science Foundation (NSF). reports were developed by the SPC and approved by the We created state and district fact sheets showing the local FASEB Board. I met with NIH Director Francis Collins and returns on NIH funding. Advocates from FASEB and its his senior staff (Lawrence Tabak, Sally Rockey, and Kathy member societies made extensive use of these documents, Hudson) to discuss these reports, and I am pleased that the implementation plans released by NIH in December were largely consistent with the guidance we provided.

After 100 years, FASEB continues to be the policy voice of biomedical scientists and engineers.

FASEB took the lead in opposition to the Great Ape Protection and Cost Savings Act, which would have banned all research on great apes. Our public statements and letters to Congress, while supporting the Institute of Medicine (IOM) recommendation for limiting the use of chimpanzees in President-Elect Dr. Judith Bond recognizing attendees at FASEB’s research, pointed out the danger of a legislative prohibition centennial picnic celebration and the implications of a ban on certain types of research. as did NIH Director Francis Collins. We sent copies to all 50 In an editorial, The Chicago Tribune urged legislators to governors and mayors of districts with substantial amounts of consider the FASEB arguments. research funding, and, when the sequestration threat began FASEB actively opposed legislation limiting federal employee to loom large, we prepared special state reports showing its travel and agency support for conferences. When admin- potential impact. While the year ended without resolution of istrative policies restricted the meeting participation of the funding issues, our voice was among the strongest in government scientists, we invited the leadership of the support of investment in research. American Chemical Society to join us in a discussion of federal travel and meetings policies with the Office of Management and Budget Director for Financial Management. We championed the perspective of the I was invited to represent the views of investigators at biomedical research community on a two National Academy of Sciences (NAS) meetings. Last wide range of policy issues including summer I discussed FASEB’s perspective on the IOM’s draft recommendations on harmonizing conflict of interest workforce and animal research. and was subsequently asked to serve on this committee’s Implementation Steering Group. In the fall I spoke to a To strengthen our relationships with our advocacy partners, I committee updating the NAS guide on research integrity and discussed funding and regulatory issues with the presidents the responsible conduct of research. of the Association of American Medical Colleges, National Association for Biomedical Research, and Research!America. After 100 years, FASEB continues to be the policy voice of I met with the NSF Director Subra Suresh, Deputy Director biomedical scientists and engineers. We are committed to Cora Marrett, and Assistant Director for Biology John making sure that their contributions to knowledge, health, Wingfield to discuss NSF support for research. I hosted a and quality of life continue, and I am confident that with the support of our member societies it will.

FASEB Annual Report 2012 3 Executive Director’s Report Guy Fogleman, PhD

The celebration of FASEB’s centennial year in 2012 increased our visibility and expanded our advocacy efforts. Thanks to the work of Judy Bond, Bill Talman, and Joe FASEB’s Office of Public Affairs (OPA) worked to implement LaManna, and to the generous support of our member many aspects of FASEB’s Strategic Map. For example, OPA societies, FASEB raised over $250,000 to support centennial hosted two Capitol Hill days in 2012. Our largest ever Hill activities. Events on Capitol Hill and on the FASEB campus Day was in May, with 43 scientists visiting over 70 congres- in September were successful and well-attended. We had sional offices. OPA also organized a successful conference more presence at member society meetings throughout on animal extremism on the FASEB campus. FASEB 2012, conducted a successful BioArt program, and initiated admitted two new member societies in 2012, the Society the development of state and district fact sheets. Three for Pediatric Research and the Society for Glycobiology. dozen people came to Cleveland at the end of December to We continued to work to increase the occupancy rate on celebrate the 100-year anniversary of FASEB’s founding at the Beaumont campus, and one nonprofit group signed a the location where the original FASEB bylaws were signed. lease to move into 4500 square feet of the Beaumont House Centennial contributors and member societies have been in 2013. Our marketing and business development efforts enthusiastic in their participation in activities associated with continued to gain traction. FASEB exhibited at scientific our time capsule, which is to be opened in fifty years and is meetings to market FASEB’s Science Research Conference now installed in the FASEB campus lobby. To support our centennial programs, we created an electronic archive of key documents and photos from FASEB’s history. FASEB Our largest ever Hill Day was in received proclamations on our centennial from the Mont- May, with 43 scientists visiting gomery County Board of Supervisors, the Senate of the State of Maryland, Senator Sherrod Brown of Ohio, and over 70 congressional offices. the Governor and Lieutenant Governor of the State of Ohio. Presidents of FASEB member societies were invited to series and society management services. As a result of and participated in the FASEB Board meeting and related these and other marketing activities, we wrote over fifty activities in May and many commented on this being an proposals to provide services to other organizations. Twelve extremely valuable experience. new contracts—seven with new clients—resulted from these proposals. Several approaches to protect FASEB from possible interest rate increases on our bond issue when our interest rate swap expires in 2018 were developed. After discussions with the Finance Committee and Board, we executed a “no-cost collar,” to be in effect during the years 2018–2023, which will cap our interest payments at three percent. We completed a successful Science Research Conference season and managed six scientific meetings for clients. Our proposal to renew our Maximizing Access to Research Careers MARC II grant received an excellent peer- review score and the National Institute of General Medical Sciences fully funded this grant for another five-year cycle, beginning in October 2012. Our publications operation is running very well and continues to be quite profitable for the Federation. Financially, The FASEB Journal had a banner year in 2012. All in all, we are well positioned to begin FASEB’s The 2012 Time Capsule in the Beaumont campus lobby. second century of advancing the life sciences!

4 www.faseb.org The Federation of American Societies for Experimental Biology Public Affairs

Maryland’s Montgomery County Council Member George Leventhal presenting President-Elect Dr. Judith Bond with a centennial proclamation at FASEB’s centennial picnic celebration. representatives. FASEB President-Elect Judith S. Bond, PhD appeared before the Appropriations Committee to ask The FASEB Office of Public Affairs (OPA) works with them to increase funding for the National Science Foun- representatives of FASEB’s 26 member societies, member dation (NSF). The Federation also submitted testimony to society staff, government officials, and advocacy partners the House and Senate Appropriations Committees on the to advance policies on behalf of working scientists. OPA conducts in-depth policy analyses, develops and executes importance of providing support for the National Institutes legislative strategies, and provides communication and of Health (NIH), the Department of Energy Office of Science technical support for all FASEB’s public policy initiatives. (DOE SC), the United States Department of Agriculture FASEB’s reputation as the voice of the biomedical research (USDA) Agriculture and Food Research Initiative (AFRI), community is such that when issues related to science and the United States Department of Veterans Affairs (VA) arise, legislators, federal agencies, and other organizations Medical and Prosthetic Research Program. seek the perspectives of FASEB’s leadership and its public affairs team. In May, FASEB was the first organization to conduct an analysis demonstrating the devastating impact that seques- Fighting Research Budget Cuts tration would have on the biomedical research enterprise. Last year brought unprecedented challenges for the The Federation also developed factsheets showing how biomedical research community: in addition to uncer- budget cuts under sequestration would impact individual tainty about the status of funding for science in FY 2013, states and shared these with every governor and mayor researchers faced the possibility of across-the-board budget in cities with major research institutions. FASEB also took cuts if lawmakers failed to agree on a plan to reduce the the message to Capitol Hill: On May 16th, OPA brought 43 deficit. FASEB rose to the challenge, rallying the research researchers representing a wide variety of scientific disci- community and pressing lawmakers to sustain funding for plines to Washington to deliver FASEB’s FY 2013 funding research. Early in the year, FASEB released its FY 2013 request and to urge lawmakers to avert sequestration- imposed cuts to science. FASEB’s delegation visited 70 congressional offices representing 22 states and Puerto In May, FASEB was the first Rico. Reflecting on the success of the day, President Joseph LaManna stated, “With looming risk of sequestration devas- organization to conduct an analysis tating our country’s capacity to support biomedical research, demonstrating the devastating impact it is more important than ever that scientists advocate for the sustained funding of research. I am proud of the that sequestration would have on many researchers who came together today to share this the biomedical research enterprise. important message with their elected officials.”

With the funding situation still uncertain at year’s end, “Federal Funding for Biomedical and Related Life Sciences” however, FASEB had to redouble its advocacy efforts. OPA report, which called upon Congress to provide sustainable organized another Capitol Hill Day in December that brought and predictable funding for U.S. research agencies and to “prevent further erosion in the nation’s capacity for biomedical research.” FASEB’s funding report was cited With the funding situation still uncertain in a “Dear Colleague” letter circulated by Representatives at year’s end, however, FASEB had to Markey (D-MA) and Bilbray (R-CA) and signed by 153 other redouble its advocacy efforts.

FASEB Annual Report 2012 5 14 scientists to 30 meetings. FASEB also activated its grass- roots throughout the year issuing three e-action alerts urging scientists to write to their Senators and Representatives in support of NSF and NIH funding and to take action to avoid sequestration. FASEB’s alerts generated nearly 18,000 messages to Congress.

Advocating for Animal Science

FASEB continued to lead the research community in opposition to the Great Ape Protection and Cost Savings Bio-Art competition featured investigators from across the country submitting visually compelling images generated during the course Act (GAPSCA), a bill that would prohibit the use of chim- of their research. The images were original, laboratory-based, and panzees and other great apes in biomedical research. If produced by current or former NIH-funded investigators, contractors, or trainees or members of FASEB constituent societies. adopted, GAPCSA would have severe consequences for ongoing studies to develop vaccines for hepatitis C and developing a guidance document describing the recommen- test monoclonal antibody therapies for safety. It would dations that emerged from the meeting, which was funded by also severely limit the ability to respond to emerging health grants from NIH, Covance Research Products, AstraZeneca, crises. In addition, the bill also would halt ongoing research GlaxoSmithKline, and the Association for Assessment and that could benefit great apes themselves. Last year, on two Accreditation of Laboratory Animal Care, International. separate occasions, Dr. Bond wrote to every member of the Senate asking them not to support the bill, and FASEB Cultivating the Next Generation of Scientists issued two e-action alerts to the scientific community. The alerts generated thousands of messages from scientists Last year, FASEB made recommendations to the NIH urging their lawmakers to oppose the bill. A Chicago Tribune Advisory Committee to the Director Working Groups editorial encouraged Congress to heed FASEB’s concerns, on the Biomedical Research Workforce and Workforce demonstrating that FASEB’s message was being heard by Diversity, panels formed by the NIH Director to ensure that the national media. More importantly, however, FASEB’s the nation continues to attract talented individuals to the efforts got the attention of Congress: although the bill is still research enterprise and who are reflections of the diversity problematic for the research enterprise, GAPSCA has been of the nation’s population overall. NIH announced plans amended to address some of FASEB’s concerns. to implement many of the policies FASEB recommended, including increasing postdoctoral stipends, reducing the Actions of animal rights extremists have become a serious threat to the progress of biomedical research and a worldwide concern. While most opponents of research with animals express their opposition respectfully and in accordance with the law, there is a faction that employs violent and destructive tactics designed to intimidate and harm animal scien- tists. Actions of animal rights extremists have become a serious threat to the progress of biomedical research and a worldwide concern. In June, FASEB hosted an international Bio-Art winner Dr. Matt Arnegard and Nobel Prize Winner Dr. Tom Cech at FASEB’s Centennial and NIGMS’ 50th Anniversary Celebration on summit to explore ways to prevent and mitigate animal Capitol Hill. rights extremism directed at biomedical researchers. The length of graduate training, encouraging training for a meeting brought together over 90 researchers, laboratory broader range of careers, and tracking career outcomes of veterinarians, communications experts, and security and law students and postdocs. enforcement specialists from all over the world to identify best practices for engaging the public on the importance of FASEB was especially pleased to learn that NIH will animal research and to help individuals and research institu- encourage all trainees to create an Individual Development tions to prepare for and minimize threats. FASEB is now Plan (IDP), which we have long championed as a model

6 www.faseb.org The Federation of American Societies for Experimental Biology for helping trainees explore career options and set realistic contributions basic scientists make to translational science, career and professional development goals. Last year, and facilitating their access to translational research funding FASEB went a step further: in collaboration with colleagues and resources. from the Medical College of Wisconsin, the University of California San Francisco, the American Association for the Broadening Our Reach Advancement of Science, and Science Careers, FASEB Proudly celebrating 100 years of service to the biological and biomedical sciences community developed “myIDP,” the first and only online resource to help FASEB launched the “Stand Up scientists prepare their very own IDP. This new tool provides for Science” competition in the trainees with exercises to guide them through the process fall of 2012 to encourage new Stand Up for Science! of assessing their career skills, interests, and values; an advocates for research. The

extensive list of resources for each of 20 common scientific competition offered prizes for We Support Scientists By: • Advocating for funding for biological research • Advancing policies that facilitate research and reduce regulatory burden career paths; and guidance on exploring career options and the most effective demonstration • Improving the environment for science training and education FASEB, the voice of biological and biomedical researchers, represents 26 scientific societies and over 100,000 scientists and engineers. setting professional development goals. of how research funded by NIH, Join our e-Action Alert Help us communicate with Congress on key research issues by visiting www.faseb.org/StandUp to join our e-Action list and keep up with the latest policy news. NSF, and other federal agencies Join a FASEB Member Society Benefits include reduced fees for scientific meetings, conferences, and journals; access to continuing education, professional development and career resources; and opportunities With support from the National Institute of General Medical to contribute to science policy, advocacy, and public education. The American Physiological Society Society for Developmental Biology Environmental Mutagen Society improves the health, quality of life, American Peptide Society American Society for Biochemistry and International Society for Computational Biology Molecular Biology Association of Biomolecular Resource Facilities American College of Sports Medicine American Society for Pharmacology and The American Society for Bone and Mineral Biomedical Engineering Society Sciences, FASEB organized a career development Experimental Therapeutics Research Genetics Society of America American Society for Investigative Pathology American Society for Clinical Investigation or economy in local communities. American Society for Nutrition Society for the Study of Reproduction American Federation for Medical Research The American Association of Immunologists Teratology Society The Histochemical Society American Association of Anatomists The Endocrine Society Society for Pediatric Research workshop in The Protein Society The American Society of Human Genetics Society for Glycobiology Competitors were encouraged to March to help 2012 FASEB Centennial Ad-Full-8.indd 1 2/2/12 10:40 AM create rallies, exhibits, science fairs Stand Up for Science, an ad campaign postdoctoral designed to bring awareness to FASEB’s and videos to highlight the value of advocacy efforts researchers federally funded research. The grand transition to prize winner, to be announced in 2013, will be awarded independent $10,000. positions. The conference FASEB is also continuing to expand its use of social media brought 156 to reach new audiences. In collaboration with FASEB’s postdocs and 32 Marketing and Business Development Department, OPA myIPD, an interactive, online career planning tool based on FASEB’s Individual Development Plan, expert speakers generated engaging content for Facebook which led to guides users through the process of self-assessment, the tripling of user “likes” in 2012. FASEB won gold, silver, career exploration, and setting short- and long-term together to career goals. discuss how to and bronze #Netbadge Awards for its use of Twitter to secure and thrive in an independent investigator position. disseminate science policy information. Our communica- Trainees were provided with information on career options, tions staff has also worked with our funding opportunities, interviewing techniques, strategies for member societies to create videos the pre-tenure career stage, and tips on work-life balance. documenting the experiences their investigators have when advo- cating for research support on Engaging Basic Scientists in Capitol Hill. FASEB hopes these Translational Research videos will help encourage more In March, FASEB released the proceedings of its Engaging scientists to get involved in grass- Basic Scientists in Translational Research: Identifying roots advocacy. Opportunities, Overcoming Obstacles symposium. The Although FASEB has seized symposium explored the role that basic investigators play in new methods of communicating moving research discoveries from the bench to the bedside, with scientists, policy makers, the factors that hamper their participation in translational and the public, we have not research, and ways that research institutions, funding orga- abandoned our more traditional FASEB’s Breakthroughs in Bioscience essay nizations, professional societies, scientific publishers, and “Conquering Pain and Infection…” formats. Our illustrated Break- investigators themselves can overcome these challenges. throughs in Bioscience series describes how discoveries in The meeting proceedings, which were published in the basic and clinical science have led to medical advances; Journal of Translational Medicine, provide recommendations the newer Horizons in Bioscience publication describes for training basic scientists to conduct translational research scientific discoveries on the brink of clinical application. studies, facilitating collaborations among basic and clinical Both publications are aimed at the general public and are investigators and clinicians, recognizing and rewarding the available in print and online. FASEB’s 2012 Breakthroughs

FASEB Annual Report 2012 7 article, “Conquering Pain and Behind the Scenes—Office of Public Affairs Staff Infection with Drugs from Nature’s Howard Garrison, PhD, Director, is responsible for overall Medicine Cabinet,” depicts how coordination and direction of public policy and advocacy basic research enabled scientists to activities. develop new treatments for pain and infection using compounds derived Anne M. Deschamps, PhD, Senior Science Policy Analyst, specializes in issues related to the humane use of animals in from natural products. Our 2012 research and education and translational research. Horizons article, “Optogenetics: Illuminating the Brain,” explores Bethany Drehman, PhD, Science Policy Analyst, is the most how researchers can use light- recent addition to the OPA staff and is responsible for policy responsive proteins and genetic issues related to the NIH research portfolio, biosecurity, and targeting to control the behavior of peer review. highly specific cell populations, work Lawrence Green, Communications Specialist, oversees

FASEB’s Optogenetics: Illuminating the which could lead the way to new OPA’s media relations program, coordinates external Brain Horizons in Bioscience essay therapies for a host of devastating communications initiatives, manages the OPA web pages, human disorders. and provides research and design support on special projects.

Jennifer A. Hobin, PhD, Director of Science Policy, directs FASEB’s science policy portfolio, serves as the staff liaison to the Science Policy Committee, and is responsible for issues related to graduate and postdoctoral training, clinical and translational research, and peer review.

Karen Mowrer, PhD, Legislative Affairs Officer, assists with FASEB’s overall legislative affairs program and has respon- sibility for efforts pertaining to appropriations for the DOE, NSF, and VA.

Kim Ngo, Public Affairs Assistant, organizes communica- tions with the FASEB Board, committees, and societies and assists with the smooth functioning of OPA overall.

Tyrone Spady, PhD, Legislative Affairs Officer, assists with FASEB’s overall legislative affairs program and has respon- sibility for efforts pertaining to appropriations for the DOE, NSF, and VA. FASEB’s President-Elect Dr. Judith Bond and Board Member Dr. Joseph R. Haywood at FASEB’s Centennial and NIGMS’ 50th Anniversary Jennifer Zeitzer, Director of Legislative Relations, directs the Celebration on Capitol Hill FASEB Capitol Hill Office and represents FASEB in commu- nications with the U.S. Congress. She develops legislative FASEB’s alerts generated nearly strategies and coordinates our efforts with those of our chief advocacy partners. 18,000 messages to Congress.

Office of Public Affairs Publications in 2012 ▪▪ Conquering Pain and Infection with Drugs from Nature’s ▪▪ Federal Funding for Biomedical and Related Life Sciences Medical Cabinet (www.faseb.org/Breakthroughs) Research FY2013 (www.faseb.org/FederalFundingFY2013) ▪▪ Education and Employment of Biological and Medical ▪▪ NIH Research Funding Trends: FY 1995-2012 (www.faseb. Scientists 2012: Data from National Surveys (www.faseb.org/ org/NIHFundingTrend) EducationandEmployment) ▪▪ Optogenetics: Illuminating the Brain (www.faseb.org/ ▪▪ Engaging Basic Scientists in Translational Research (www. Horizons) faseb.org/TranslationalReport)

8 www.faseb.org The Federation of American Societies for Experimental Biology MARC: Maximizing Access to Research Careers

Philly Love.

The Minority Access to Research Careers (MARC) Program 2012 MARC Program Activity Report was created by the National Institute of General Medical Sciences, National Institutes of Health (NIGMS/NIH) ▪▪ Science Research Conferences Travel Awards to increase the number of biomedical and behavioral »»5 graduate students scientists from underrepresented minority groups. A key »»6 postdoctorates objective of the NIGMS/NIH Program is the encouragement of underrepresented minority students in the pursuit ▪▪ Grantsmanship Training/Leadership Development of graduate training leading to the PhD degree in the Seminar Travel Awards biomedical sciences. »»1 seminar sponsored »»20 junior faculty/postdoctorates/graduate students FASEB has supported the training of minority scientists for ▪▪ Summer Research Opportunity Program Travel and over 30 years through MARC grants that involve a variety Subsistence Awards of programs and activities carried out by the Office of »»48 students Maximizing Access to Research Careers and Professional »»29 mentors Development (FASEB MARC): »»12 host institutions ▪▪ Support for FASEB societies’ diversity program initiatives ▪▪ Travel Awards for faculty and students to attend FASEB 2012 FASEB Society Partner Travel Awards societies’ scientific meetings and conferences ▪▪ APS 11 ▪▪ SSR 8 ▪▪ Travel Awards for poster/oral presenters (students and postdoctoral fellows) to attend FASEB societies’ scientific ▪▪ ASBMB 15 ▪▪ TES 18 meetings and conferences ▪▪ ASPET 14 ▪▪ ASHG 21 ▪▪ Travel Awards for minority scientists, senior postdoctoral ▪▪ ASIP 13 ▪▪ ISCB 4 fellows, and graduate students to attend FASEB Science ▪▪ ASN 10 ▪▪ ACSM 44 Research Conferences ▪▪ AAI 33 ▪▪ BMES 12 ▪▪ Travel/Subsistence Awards for undergraduate students to participate in summer research opportunity programs at ▪▪ PS 3 ▪▪ GSA 10 major research institutions and universities ▪▪ SDB 14 ▪▪ HCS 5 ▪▪ Sponsoring grantsmanship training seminars and ▪▪ ASBMR 7 ▪▪ SFG 2 workshops at scientific meetings during the summer ▪▪ ASCI 1 sessions, and on the campuses of minority institutions ▪▪ Sponsoring career development programs and activities for Non-FASEB Society Meetings minority researchers and students during the Experimental Biology Annual Meeting and a select group of other FASEB ▪▪ FASEB MARC ▪▪ SACNAS 20 societies’ meetings at EB2012 76 ▪▪ CFD 12 ▪▪ Support for the FASEB MARC Program Advisory Board ▪▪ ABRCMS 72 ▪▪ ISAC 1 Annual Meeting ▪▪ Hosting FASEB MARC Program activities and InfoNet on TOTAL AWARDS 426 the FASEB website

FASEB Annual Report 2012 9 The FASEB

Journal The FASEB Journal March 2012 cover

It is now seven years since our editorial board assumed responsibility for The FASEB Journal, and we report continued progress.

Publishing Performance Impact Factor and Reputation The reassuring aspect of our performance has been the total Citations and Impact Factor of The FASEB Journal number of visits to our journal in the past year. Including 5 Year known Web Crawlers, the journal received more than 9.4 Year Pages Articles Citations Impact factor million hits in 2012 versus 4.7 million hits in 2005! 2012 5200 468 N/A N/A

Performance of The FASEB Journal 2011* 4539 409 38,304 6.3

Percent 2010 5123 462 38,538 7.2 Year Submissions Turnaround Accepted Web Hits 2006 2622 449 30,621 6.7 2012 1861 94.6 22 8,053,123* * Latest available. There is a two year lag from the June reporting date. 2011 1935 98.3 23.3 7,353,177*

2010 2263 99.7 17.1 6,295,986* We receive more than 38,000 citations for up to 468 articles 2005 1670 101.9 27.0 4,741,356** published per annum and our 5-year impact factor is *excludes known Web crawlers **includes Web crawlers comfortably above 6.

We now receive more than 150 initial query (IQ) submissions a month, versus a peak of 190 in 2010. As in the past five Editorial Board Changes years, 20-24% of submissions are from the U.S. We used Although we no longer have the invaluable services of Kim the same criteria for acceptance as in 2010 and since our Barrett, Jon Morrow and John Wysolmerski, we welcome acceptance rate rose, we are clearly getting better submis- the new Board Members Hershel Raff, William G. Stetler- sions. We also had fewer papers with excess supplemental Stevenson and Janet Hock. Hershel Raff, Medical College of data (supplemental data requirements were drastically Wisconsin, is an authority on Cushing’s syndrome, adrenal lowered at the request of the board). Journal turnaround tumors, fetal and neonatal endocrinology and metabolism. times remain strong: William G. Stetler-Stevenson is at the National Cancer ▪▪ The time from submission to acceptanc